63 results
Page 2 of 4
8-K
66q1 16j7c5gmrnw2n4
3 Feb 21
Other Events
5:25pm
424B5
qi36xofo6bzh
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
y3g ou8xu14jaruv
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
xxt8d 5mm33dvwc68
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
min7xb ks7
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
424B3
tzk3neub6ao
28 Aug 20
Prospectus supplement
4:31pm
425
3fmts
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.4
udokwd p7
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
zzmntpzjk7nolqxjo
6 Aug 19
Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume
4:17pm